ARTICLE | Company News
PsychoGenics, Roche deal
June 2, 2008 7:00 AM UTC
PsychoGenics will use its drug discovery technologies to evaluate undisclosed compounds from Roche to treat neuropsychiatric disorders. Either company has an option to exclusively develop resulting co...